{"id":147269,"date":"2022-09-30T11:22:39","date_gmt":"2022-09-30T16:22:39","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/09\/alzheimers-drug-study-yields-positive-results-say-makers-eisai-and-biogen"},"modified":"2022-09-30T11:22:39","modified_gmt":"2022-09-30T16:22:39","slug":"alzheimers-drug-study-yields-positive-results-say-makers-eisai-and-biogen","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/09\/alzheimers-drug-study-yields-positive-results-say-makers-eisai-and-biogen","title":{"rendered":"Alzheimer\u2019s drug study yields positive results, say makers Eisai and Biogen"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/alzheimers-drug-study-yields-positive-results-say-makers-eisai-and-biogen2.jpg\"><\/a><\/p>\n<p>Sept 27 (Reuters) \u2014 An experimental Alzheimer\u2019s drug made by Eisai Co Ltd <a data-testid=\"Link\" href=\"https:\/\/www.reuters.com\/companies\/4523.T\" target=\"_blank\" class=\"\">(4523.T)<\/a> and Biogen <a data-testid=\"Link\" href=\"https:\/\/www.reuters.com\/companies\/BIIB.O\" target=\"_blank\" class=\"\">(BIIB.O)<\/a> slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs.<\/p>\n<p>Multiple drugmakers have so far tried and <a data-testid=\"Link\" href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/eisai-biogen-alzheimers-drug-success-follows-many-failures-2022-09-27\/\" class=\"\">failed<\/a> to find an effective treatment for the brain-wasting disease that affects about 55 million people globally. A breakthrough would be a major boost to similar studies being run by Roche and Eli Lilly.<\/p>\n<p>Speaking of the Eisai-Biogen drug results announced late on Tuesday night, Ronald Petersen, director of the Mayo Clinic Alzheimer\u2019s Disease Research Center in Rochester, Minnesota said: \u201cIt\u2019s not a huge effect, but it\u2019s a positive effect\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sept 27 (Reuters) \u2014 An experimental Alzheimer\u2019s drug made by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs. Multiple drugmakers have so far [\u2026]<\/p>\n","protected":false},"author":661,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,47],"tags":[],"class_list":["post-147269","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-neuroscience"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/147269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/661"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=147269"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/147269\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=147269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=147269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=147269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}